Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$602.02 USD
+3.99 (0.67%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $601.70 -0.32 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$602.02 USD
+3.99 (0.67%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $601.70 -0.32 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
NextGen's (NXGN) HDH to Facilitate Health Information Exchange
by Zacks Equity Research
NextGen's (NXGN) HDH has been chosen by HI-BRIDGE HIE for secure sharing of patient health data from multiple sources.
Abbott (ABT) Launches Immunity Boosting Hydration Solution
by Zacks Equity Research
Abbott's (ABT) latest hydration solution with specifically chosen nutrients along with optimal balance of electrolytes and glucose is expected to boost immunity.
Masimo (MASI) Releases Favorable Findings on Pulse Oximetry
by Zacks Equity Research
Researchers on probe discover that the use of Masimo's (MASI) SpHb was related to the lower rate of postoperative transfusion, minimal duration of ICU stay and other better outcomes.
NEOGEN (NEOG) Launches DNA Screening Tool for Canine Care
by Zacks Equity Research
NEOGEN's (NEOG) latest DNA screening tool is expected to aid veterinarians to provide healthy lifestyle recommendations for a longer and happier life for each pet and its family.
Here's Why You Should Retain Fresenius Medical (FMS) Stock
by Zacks Equity Research
Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.
Cerner's (CERN) Simplified Digital Tools to Aid Health Systems
by Zacks Equity Research
Cerner (CERN) offers centralized digital ordering and monitoring for clients in order to help health systems.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $471.39, moving +0.57% from the previous trading session.
Zimmer Biomet (ZBH), HSS Partner to Advance Remote Patient Care
by Zacks Equity Research
Zimmer Biomet's (ZBH) mymobility with Apple Watch platform aids in transforming virtual patient care via the latest partnership with HSS.
Here's Why You Should Hold on to McKesson (MCK) Stock Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
Simbec-Orion to Adopt Veeva's (VEEV) Vault Applications
by Zacks Equity Research
Veeva's (VEEV) clinical solutions will offer Simbec-Orion real-time insights into studies in phases to accelerate trial execution.
The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic
LabCorp's (LH) Pixel Kit Gets EUA for Over-the-Counter Use
by Zacks Equity Research
This approval is expected to increase access to LabCorp's (LH) COVID-19 testing, thereby broadening its customer base.
Cerner's (CERN) Deal to Make Clinical Trials More Accessible
by Zacks Equity Research
Cerner (CERN) inks deal with Elligo Health Research to make clinical trials more accessible, while minimizing costs.
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
by Zacks Equity Research
Investors grew bullish on Nevro's (NVRO) prospects, courtesy of the stock's solid prospects.
Zacks.com featured highlights include: Lennar Corp, TeleTech Holdings, Activision Blizzard, Thermo Fisher Scientific and ParkerHannifin
by Zacks Equity Research
Zacks.com featured highlights include: Lennar Corp, TeleTech Holdings, Activision Blizzard, Thermo Fisher Scientific and ParkerHannifin
Medtronic (MDT) Carpediem to Tap Pediatric Kidney Care Market
by Zacks Equity Research
Medtronic's (MDT) Carpediem CRRT system compares favorably with the traditional three times a week therapy session.
Bruker (BRKR) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Bruker (BRKR) is optimistic about maintaining a robust product portfolio along with its continued COVID-19-led progress.
Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access
by Zacks Equity Research
Illumina (ILMN) signs agreement to expand the availability of WGS to enable faster and cost-effective diagnosis of genetic diseases in children.
4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021
by Trina Mukherjee
Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.
HealthEquity (HQY) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity (HQY) delivers strong growth in Service, Custodial and Interchange segments in Q3.
3 Reasons Growth Investors Will Love Thermo Fisher (TMO)
by Zacks Equity Research
Thermo Fisher (TMO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
QIAGEN (QGEN) Launches RUO Solution to Explore Immune Response
by Zacks Equity Research
QIAGEN's (QGEN) latest RUO solution is expected to provide better insights into the course of the COVID-19 infection and aid in vaccine development and deployment.
LabCorp (LH) Covance Arms Shows Momentum Amid COVID-19 Woes
by Zacks Equity Research
In oncology too, LabCorp (LH) receives a significant award to be the partner of choice for late-stage oncology studies from a major pharmaceutical company.
NuVasive (NUVA) Focuses on Cervical Spine Portfolio Expansion
by Zacks Equity Research
The ACP system within NuVasive (NUVA) C360 is targeted to reduce common postoperative complications such as dysphagia, malalignment and adjacent level ossification.
5 Top-Ranked Stocks With Solid Dividend Growth to Bet On
by Sweta Killa
These dividend growth stocks have superior fundamentals, making them quality and promising investments for the long term.